Usio, Inc. announced it will release its third quarter fiscal 2026 financial results after market close on November 10, 2026. The company will host a conference call the same day at 4:30 p.m. Eastern time to discuss the results and provide a business update, followed by a Q&A session. Investors and analysts can participate via phone or live webcast. This event is important as it offers insights into Usio's financial health and strategic direction for the coming period.
Usio's upcoming third quarter fiscal year 2026 results conference call is scheduled for November 10, 2026. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 02, 2026 22:41 WIB: out of 142 priced US Financials stocks tradable on Pluang, 124 rose and 17 fell. Notable movers include AFRM at USD 77.70 with a +5.73% change and a typical hold time of 21 days, BAM at USD 50.95 with a +5.57% change and a 12-day hold time, and APO at USD 121.36 with a +4.79% change and a 71-day hold time.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
